553 related articles for article (PubMed ID: 23211635)
1. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
[TBL] [Abstract][Full Text] [Related]
4. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
Kirkizlar E; Serban N; Sisson JA; Swann JL; Barnes CS; Williams MD
Ophthalmology; 2013 Dec; 120(12):2604-2610. PubMed ID: 24084501
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
8. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.
van Katwyk S; Jin YP; Trope GE; Buys Y; Masucci L; Wedge R; Flanagan J; Brent MH; El-Defrawy S; Tu HA; Thavorn K
Value Health; 2017 Sep; 20(8):1034-1040. PubMed ID: 28964434
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.
Xie Y; Nguyen QD; Hamzah H; Lim G; Bellemo V; Gunasekeran DV; Yip MYT; Qi Lee X; Hsu W; Li Lee M; Tan CS; Tym Wong H; Lamoureux EL; Tan GSW; Wong TY; Finkelstein EA; Ting DSW
Lancet Digit Health; 2020 May; 2(5):e240-e249. PubMed ID: 33328056
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.
Ben ÂJ; Neyeloff JL; de Souza CF; Rosses APO; de Araujo AL; Szortika A; Locatelli F; de Carvalho G; Neumann CR
Appl Health Econ Health Policy; 2020 Feb; 18(1):57-68. PubMed ID: 31674001
[TBL] [Abstract][Full Text] [Related]
12. Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults.
Sharafeldin N; Kawaguchi A; Sundaram A; Campbell S; Rudnisky C; Weis E; Tennant MTS; Damji KF
Br J Ophthalmol; 2018 Nov; 102(11):1485-1491. PubMed ID: 29680803
[TBL] [Abstract][Full Text] [Related]
13. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
[TBL] [Abstract][Full Text] [Related]
14. Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
Lin J; Chang JS; Smiddy WE
Ophthalmology; 2016 Sep; 123(9):1912-8. PubMed ID: 27425822
[TBL] [Abstract][Full Text] [Related]
15. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.
Vijan S; Hofer TP; Hayward RA
JAMA; 2000 Feb; 283(7):889-96. PubMed ID: 10685713
[TBL] [Abstract][Full Text] [Related]
16. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
[TBL] [Abstract][Full Text] [Related]
17. Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi.
Vetrini D; Kiire CA; Burgess PI; Harding SP; Kayange PC; Kalua K; Msukwa G; Beare NAV; Madan J
PLoS One; 2018; 13(1):e0190742. PubMed ID: 29300755
[TBL] [Abstract][Full Text] [Related]
18. [Health economic evaluation of telemedicine diabetic retinopathy examination using a non-mydriatic fundus camera in China].
Fan JX; Zhang M; Zhao WY; Han Y; Hu WT; Jia HX; Sun XD
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):919-929. PubMed ID: 37936360
[No Abstract] [Full Text] [Related]
19. Cost Analysis of Teleophthalmology Screening for Diabetic Retinopathy Using Teleophthalmology Billing Codes.
Ellis MP; Bacorn C; Luu KY; Lee SC; Tran S; Lillis C; Lim MC; Yiu G
Ophthalmic Surg Lasers Imaging Retina; 2020 May; 51(5):S26-S34. PubMed ID: 32484898
[TBL] [Abstract][Full Text] [Related]
20. Satisfaction of patients and primary care professionals with a teleophthalmology-based screening programme for diabetic retinopathy in a rural area in Castilla y León, Spain.
Valpuesta Martin Y; Pacheco Callirgos GE; Maroto Martín TM; Piriz Veloso M; Hernández Santamaría S; López Gálvez MI
Rural Remote Health; 2020 Jan; 20(1):5180. PubMed ID: 31941342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]